Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Innovative chemical design and regulation strategies for overcoming lead toxicity in perovskite-based optoelectronics: a new perspective

Liu G., Yang G., Feng W., Wu WQ.

Narrative Review on Face & Skin, published in Chem Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Chem Sci (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41696594
PMCID
PMC12896186
DOI
10.1039/d5sc09981a
Citations
1

Abstract (original English)

The rapid rise of metal halide perovskites has revolutionized optoelectronic technologies, yet the intrinsic lead (Pb) toxicity remains a fundamental challenge threatening environmental safety and sustainable commercialization. This perspective summarizes recent advances over the past two to three years (2023-2025) in innovative chemical design and regulation strategies for Pb sequestration and immobilization within perovskite systems, encompassing both photovoltaic and luminescent devices. Key developments include embedding crosslinked supramolecular networks for Pb capture, constructing supramolecular host-guest inclusion complexes for Pb immobilization, employing chemical synergistic coordination for Pb species stabilization, and achieving lattice-matching anchoring for Pb migration suppression. Dual protection via dynamic interfacial confinement and integrated physical-chemical encapsulation further minimizes Pb leakage. In addition, the use of biocompatible supramolecular cyclodextrins for selective Pb ion chelation represents a promising route to reduce Pb toxicity at the material and environmental levels. Despite these achievements, challenges persist in ensuring scalability, long-term stability, and economic feasibility. Looking forward, future efforts should focus on intelligent Pb-sequestrating materials, Pb-free perovskite alternatives, closed-loop recycling systems,

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research